Header Logo

Connection

Mark Pollack to Neurotransmitter Uptake Inhibitors

Back to Details
This is a "connection" page, showing publications Mark Pollack has written about Neurotransmitter Uptake Inhibitors.
Mark Pollack
Connection Strength
0.234
Neurotransmitter Uptake Inhibitors
  1. The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study. J Clin Psychiatry. 2005 Nov; 66(11):1401-8.
    View in: PubMed
    Score: 0.234
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.